211 related articles for article (PubMed ID: 24863917)
1. Fabrication, characterization and bioevaluation of silibinin loaded chitosan nanoparticles.
Pooja D; Babu Bikkina DJ; Kulhari H; Nikhila N; Chinde S; Raghavendra YM; Sreedhar B; Tiwari AK
Int J Biol Macromol; 2014 Aug; 69():267-73. PubMed ID: 24863917
[TBL] [Abstract][Full Text] [Related]
2. Enhanced cytotoxicity and apoptosis-induced anticancer effect of silibinin-loaded nanoparticles in oral carcinoma (KB) cells.
Gohulkumar M; Gurushankar K; Rajendra Prasad N; Krishnakumar N
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():274-82. PubMed ID: 24907761
[TBL] [Abstract][Full Text] [Related]
3. Preparation, Characterization and Cytotoxicity of Silibinin- Containing Nanoniosomes in T47D Human Breast Carcinoma Cells.
Amiri B; Ebrahimi-Far M; Saffari Z; Akbarzadeh A; Soleimani E; Chiani M
Asian Pac J Cancer Prev; 2016; 17(8):3835-8. PubMed ID: 27644625
[TBL] [Abstract][Full Text] [Related]
4. A supersaturating delivery system of silibinin exhibiting high payload achieved by amorphous nano-complexation with chitosan.
Nguyen MH; Yu H; Dong B; Hadinoto K
Eur J Pharm Sci; 2016 Jun; 89():163-71. PubMed ID: 27140843
[TBL] [Abstract][Full Text] [Related]
5. Chitosan nanoparticle as protein delivery carrier--systematic examination of fabrication conditions for efficient loading and release.
Gan Q; Wang T
Colloids Surf B Biointerfaces; 2007 Sep; 59(1):24-34. PubMed ID: 17555948
[TBL] [Abstract][Full Text] [Related]
6. Effect of silibinin-loaded nano-niosomal coated with trimethyl chitosan on miRNAs expression in 2D and 3D models of T47D breast cancer cell line.
Yazdi Rouholamini SE; Moghassemi S; Maharat Z; Hakamivala A; Kashanian S; Omidfar K
Artif Cells Nanomed Biotechnol; 2018 May; 46(3):524-535. PubMed ID: 28509572
[TBL] [Abstract][Full Text] [Related]
7. Characterization and carboplatin loaded chitosan nanoparticles for the chemotherapy against breast cancer in vitro studies.
Khan MA; Zafaryab M; Mehdi SH; Quadri J; Rizvi MM
Int J Biol Macromol; 2017 Apr; 97():115-122. PubMed ID: 28082219
[TBL] [Abstract][Full Text] [Related]
8. Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS.
Xu P; Yin Q; Shen J; Chen L; Yu H; Zhang Z; Li Y
Int J Pharm; 2013 Sep; 454(1):21-30. PubMed ID: 23830941
[TBL] [Abstract][Full Text] [Related]
9. Alginate/Gelatin scaffolds incorporated with Silibinin-loaded Chitosan nanoparticles for bone formation in vitro.
Leena RS; Vairamani M; Selvamurugan N
Colloids Surf B Biointerfaces; 2017 Oct; 158():308-318. PubMed ID: 28711017
[TBL] [Abstract][Full Text] [Related]
10. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
11. Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers.
Raja MA; Katas H; Jing Wen T
PLoS One; 2015; 10(6):e0128963. PubMed ID: 26068222
[TBL] [Abstract][Full Text] [Related]
12. Fabrication, characterization and cytotoxicity studies of ionically cross-linked docetaxel loaded chitosan nanoparticles.
Jain A; Thakur K; Sharma G; Kush P; Jain UK
Carbohydr Polym; 2016 Feb; 137():65-74. PubMed ID: 26686106
[TBL] [Abstract][Full Text] [Related]
13. Fabrication, characterization and in vitro evaluation of silibinin nanoparticles: an attempt to enhance its oral bioavailability.
Sahibzada MUK; Sadiq A; Khan S; Faidah HS; Naseemullah ; Khurram M; Amin MU; Haseeb A
Drug Des Devel Ther; 2017; 11():1453-1464. PubMed ID: 28553075
[TBL] [Abstract][Full Text] [Related]
14. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
Zhang J; Chen XG; Li YY; Liu CS
Nanomedicine; 2007 Dec; 3(4):258-65. PubMed ID: 17962086
[TBL] [Abstract][Full Text] [Related]
15. [Synthesis and characterization of folic acid-conjugated chitosan nanoparticles as a tumor-targeted drug carrier].
Gong JL; Wang SM; Hu XG; Cao MM; Zhang JR
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2183-6. PubMed ID: 19114352
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells.
Kumar SP; Birundha K; Kaveri K; Devi KT
Int J Biol Macromol; 2015; 78():87-95. PubMed ID: 25840152
[TBL] [Abstract][Full Text] [Related]
17. Hydrophobic lapatinib encapsulated dextran-chitosan nanoparticles using a toxic solvent free method: fabrication, release property & in vitro anti-cancer activity.
Mobasseri R; Karimi M; Tian L; Naderi-Manesh H; Ramakrishna S
Mater Sci Eng C Mater Biol Appl; 2017 May; 74():413-421. PubMed ID: 28254312
[TBL] [Abstract][Full Text] [Related]
18. Characterization and anti-proliferative activity of curcumin loaded chitosan nanoparticles in cervical cancer.
Khan MA; Zafaryab M; Mehdi SH; Ahmad I; Rizvi MM
Int J Biol Macromol; 2016 Dec; 93(Pt A):242-253. PubMed ID: 27565296
[TBL] [Abstract][Full Text] [Related]
19. Chitosan/PLA nanoparticles as a novel carrier for the delivery of anthraquinone: synthesis, characterization and in vitro cytotoxicity evaluation.
Jeevitha D; Amarnath K
Colloids Surf B Biointerfaces; 2013 Jan; 101():126-34. PubMed ID: 22796782
[TBL] [Abstract][Full Text] [Related]
20. Silibinin and indocyanine green-loaded nanoparticles inhibit the growth and metastasis of mammalian breast cancer cells in vitro.
Sun HP; Su JH; Meng QS; Yin Q; Zhang ZW; Yu HJ; Zhang PC; Wang SL; Li YP
Acta Pharmacol Sin; 2016 Jul; 37(7):941-9. PubMed ID: 27133295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
